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The reference column of [Table 1](#t1-jbm-4-057){ref-type="table"} was incorrect in the published version. The correct [Table 1](#t1-jbm-4-057){ref-type="table"}, also amended for clarity, is below.

###### 

Pharmacokinetic properties of von Willebrand Factor-containing concentrates

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Product                  In vivo vWF:RCo recovery (IU/dL per IU/kg)   In vivo FVIII recovery (IU/dL per IU/kg)   vWF:RCo/FVIII ratio   Source of plasma               Viral inactivation       Vial sizes (IU)   Reference
  ------------------------ -------------------------------------------- ------------------------------------------ --------------------- ------------------------------ ------------------------ ----------------- -----------
  **Alphanate**            2.9 ± 1.3 (mean ± SD)                        2.1 ± 0.4 (mean ± SD)                      1.6:1                 USA                            SLD\                     250\              \(32\)
                                                                                                                                                                        Dry heat\                500\              
                                                                                                                                                                        (80°C for 72 hrs)        1000\             
                                                                                                                                                                                                 1500              

  **Biostate**             0.85 (0.77--0.92) mean (90% CI)              1.1 (0.88--1.32) mean (90% CI)             2.1:1                 Australia                      SLD\                     250\              \(29\)
                                                                                                                                                                        Dry heat\                500               
                                                                                                                                                                        (80°C for 72 hrs)                          

  **Factor 8Y**            Type 3: 1.4 ± 0.05\                          Type 3: 2.4 ± 1.1\                         2:1                   USA                            Dry heat\                250\              \(31\)
                           Type 2A: 2.0 ± 0.06\                         Type 1: 5.0 ± 4.5\                                                                              (80°C for 72 hrs)        500               
                           Type 1: 2.3 ± 0.5 (mean ± SD)                (mean ± SD)                                                                                                                                

  **Fanhdi**               1.9 ± 0.6                                    2.6 ± 0.6                                  1.6:1                 USA                            SLD\                     250\              (33,34)
                                                                                                                                                                        Dry heat\                500\              
                                                                                                                                                                        (80°C for 72 hrs)        1000\             
                                                                                                                                                                                                 1500              

  **Haemate P/Humate P**   2.1 (1.1--2.7) median (range)                2.7 (1.9--3.7) median (range)              2.5:1                 USA, Austria, Germany          Pasteurized\             500\              \(28\)
                                                                                                                                                                        (60°C for 10 hrs)        1000              

  **Wilfactin**            2.1 ± 0.3                                    5.8 ± 1 IU/dL (FVIII synthesis rate)       10:1                  Germany, France, Switzerland   SLD\                     1000              \(30\)
                                                                                                                                                                        Dry heat\                                  
                                                                                                                                                                        (80°C for 72 hrs)\                         
                                                                                                                                                                        Nanofiltration (35 nM)                     
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**Abbreviations:** SLD, solvent detergent, in viral inactivation column; SD, standard deviation in columns 2 and 3; vWF, von Willebrand factor; vWD, von Willebrand disease; vWF:RCo, vWF ristocetin cofactor.
